Summary of Dongfang Zhenxuan Conference Call Company Overview - **Company**: Dongfang Zhenxuan - **Industry**: E-commerce and Live Shopping Key Points and Arguments - **Multi-Platform Strategy**: Dongfang Zhenxuan employs a multi-platform strategy, with Douyin contributing approximately 80% of GMV, forming the company's core base. The company is also expanding into other e-commerce platforms like Taobao, JD.com, Xiaohongshu, and Pinduoduo without paid promotions [2][5] - **Brand Exposure Initiatives**: The company plans to utilize vending machines at New Oriental education institutions for brand exposure and will host family public welfare lectures to share product development concepts and brand stories, aiming to reach a broader potential user base [2][6] - **APP Development**: The Dongfang Zhenxuan APP focuses on self-operated products, achieving a 30-day repurchase rate of 50%. The company aims to increase app downloads and paid memberships through marketing activities, potentially including online concerts to attract users [2][7] - **Product Range and Quality Assurance**: The company offers 600 SKUs of self-operated products, with 300 available year-round. It employs big data to understand consumer needs and iterates on products while enhancing product quality through multi-layered quality control measures [2][10][9] - **Cost Reduction and Efficiency Improvement**: The company is implementing cost reduction and efficiency improvement plans, optimizing internal structures, and reducing full-time staff to enhance profitability [4][13][16] - **Self-Operated Product Performance**: Self-operated products account for about 50% of total sales, with plans to strengthen partnerships for broader distribution. The company focuses on health-related products and basic necessities for 2025 [11][12][17] Additional Important Content - **GMV Distribution**: The self-operated APP contributes approximately 15%-20% of total GMV, while Douyin and shelf e-commerce account for over 80% [4][18] - **Live Streaming Operations**: Dongfang Zhenxuan operates nearly ten accounts on Douyin, with the fresh produce account performing particularly well, achieving daily GMV exceeding 2 million RMB [4][21] - **Membership Growth Strategy**: The company is focusing on expanding paid membership through initiatives like the "亲友卡" (Friend and Family Card) to enhance user interaction and increase membership numbers [29][28] - **Future Plans for Product Development**: The company plans to introduce new health-related products and optimize existing offerings based on market data and user feedback [11][9] - **Stock Buyback and Incentive Plans**: The company initiated a 500 million RMB stock buyback plan last year, with 100 million RMB utilized so far. Future stock buybacks may occur based on management directives [30][31] - **Technological and Supply Chain Enhancements**: The company is focusing on optimizing its supply chain and technology systems to support growth and is considering selling self-operated products on other platforms to expand market share [32]

Summary of Ant Group's IPO Discussion Company and Industry - **Company**: Ant Group Co. Ltd. - **Industry**: Fintech, specifically focusing on digital payments and financial technology Core Points and Arguments - Ant Group is in discussions with regulators for an IPO of its international unit, Ant International, in Hong Kong, with no current policy obstacles indicated [3][4][5] - The company is 33% controlled by Alibaba Group, and recent governance restructuring has allowed Ant Group to potentially revive its stalled IPO [6][7] - Jack Ma, the founder, reduced his voting rights from 53.46% to just over 6% as part of a broader overhaul following regulatory crackdowns in 2020 [6][7] - Under current IPO regulations, a change in actual control allows Ant Group to list in Hong Kong as soon as early 2024 [8] - Ant Group initially announced its IPO intentions in July 2020, aiming to raise $34.5 billion, but the application was suspended in November 2020 due to regulatory changes [9][10] - Recent developments, such as the acquisition of a controlling stake in Bright Smart Securities, have fueled speculation about the revival of the IPO [11][12] - Market insiders believe a backdoor listing through Bright Smart Securities is unlikely due to regulatory challenges [13][15] Additional Important Information - Ant International, headquartered in Singapore, has seen its revenue contribution grow from approximately 5% in 2020 to around 20% by 2024, with an estimated market valuation of 200 billion yuan ($27.8 billion) [17][18] - The company started in 2015, focusing on cross-border payments for Chinese tourists and has expanded its operations significantly in Southeast Asia [19] - Ant Group is also enhancing its overseas lending business through platforms like Anext Bank and Bettr, targeting small and midsize businesses [20]

Summary of the Conference Call for Xindong Company Company Overview - Xindong Company primarily consists of two business segments: TapTap platform (game community and distribution channel, approximately 30% of revenue) and game business (approximately 70% of revenue) [2][4] Key Points and Arguments - In 2024, Xindong Company launched two core games, "Start Your Adventure, Muffin" and "Xindong Town," which exceeded expectations. "Start Your Adventure, Muffin" generated total revenue of 1.6 billion RMB, with confirmed income of about 1.5 billion RMB; "Xindong Town" confirmed revenue of less than 300 million RMB by year-end, with a total revenue of approximately 400 million RMB [2][7] - The success of "Start Your Adventure, Muffin" is attributed to its casual gameplay and social attributes, which reduced player churn, showcasing the company's experience in developing team-based idle games [2][10] - In 2025, "Start Your Adventure, Muffin" underperformed in the Japanese market, and the domestic version faces downward pressure, while "Xindong Town" is expected to contribute an additional 300-400 million RMB domestically, potentially offsetting overall declines [2][12][13] - Older games like "Sausage Party" are expected to see a natural decline of about 10%, while "Bellflower Sword" may see a 50% drop in revenue. However, "Torchlight" is expected to exceed last year's revenue of 300 million RMB due to shortened season cycles and content updates [2][12] Financial Performance - Xindong Company's 2024 financial performance met market expectations, but stock prices fell due to discrepancies between operational data and market forecasts. Future game revenue may show fluctuations, presenting investment opportunities [3] - TapTap platform's monthly active users (MAU) were approximately 44 million in 2024, with expectations for double-digit revenue growth in 2025 and profit margins increasing from 25% in 2024 to around 30% in 2025, potentially yielding profits of 500 million RMB or more [5][28] Market and Valuation Insights - TapTap platform's MAU showed resilience despite a decline in advertising investment. The company experienced a valuation and performance downturn but saw a recovery in 2024 due to a strong product cycle [6] - The valuation for Xindong Company is projected between 14 billion to 20 billion RMB, with a PE ratio of 10 to 15 times, depending on the performance of new games like "Ise" [30] Future Game Releases and Expectations - The new game "Ise" is expected to launch in June 2025, with revenue contributions estimated at 300 million RMB if performance is average, and up to 1 billion RMB if successful [5][16] - Xindong Company plans to continue expanding its self-developed team, currently consisting of over 700 members, and aims to launch one to two new projects in 2025 [19][20] Additional Considerations - The company is focusing on enhancing user engagement on the TapTap platform, with strategies to improve user stickiness and maintain a balance between ad loading rates and user growth [26] - The overall game business is expected to grow by 20% in 2025, with a stable profit margin projected between 60% to 65% [29] This summary encapsulates the key insights and projections regarding Xindong Company and its operational landscape, highlighting both opportunities and challenges in the gaming industry.

Summary of Lianlian Digital Conference Call Company Overview - Lianlian Digital is the largest independent digital payment solution provider in China, holding 65 global payment licenses and supporting transactions in over 130 currencies, serving more than 100 e-commerce platforms globally, with a strong global layout and compliance framework as its core competitive advantage [2][3][5] Financial Performance - In 2024, Lianlian Digital's Total Payment Volume (TPV) grew by 64.7%, and revenue increased by 27.9% to 1.315 billion RMB, with global payment revenue accounting for 61.4% and a gross margin of 72%, indicating strong growth momentum and profitability [2][13] Business Model and Services - The company provides a one-stop solution for cross-border e-commerce payment services, including acquiring, collection, currency exchange, trade declaration, and subsequent logistics services [3][4] - Lianlian Digital collaborates with logistics companies like Zhongyuan Shipping to offer comprehensive fund flow and logistics services [2][8][9] Market Expansion and Strategy - The company is actively expanding its global business, focusing on the Middle East and Latin America, with plans to obtain a payment license in the Middle East by 2025 [2][12][19] - Lianlian Digital is exploring the application of Web3 technology in cross-border payments and has obtained a virtual asset exchange license in Hong Kong [2][27] Competitive Landscape - The cross-border payment industry faces significant barriers, including licensing and compliance requirements, with Lianlian Digital being the only non-U.S. company to hold payment licenses in all 50 U.S. states [6][17] - The market is highly concentrated, with major players holding approximately 80% of the market share, indicating intense competition [15][16][30] Management and Team - The management team has extensive industry experience, with the CEO and COO having significant backgrounds in technology and finance [10][11] Regulatory Environment - Recent financial facilitation policies from the Shanghai government are expected to positively impact the company by enhancing cross-border settlement efficiency and financial services [26] Future Outlook - Lianlian Digital's future strategy includes further global expansion, particularly in the Middle East and Latin America, and leveraging existing licenses for localized operations to mitigate tariff increases and geopolitical risks [12][19] - The company anticipates a slowdown in TPV growth to 30-40% in 2026, emphasizing the importance of revenue growth as a core competitive metric [32] Challenges and Risks - The company faces challenges in customer acquisition compared to e-commerce giants like Alibaba, as its customer base primarily consists of small and micro enterprises [20][21] - The stock price has been volatile due to large shareholder unlocks and market dynamics, with strategies in place to stabilize it [33] Technology and Innovation - Lianlian Digital is committed to integrating AI and Web3 technologies into its payment processes to enhance efficiency and reduce costs [12][27] Conclusion - Lianlian Digital is well-positioned in the cross-border payment industry with a robust growth trajectory, strong management, and a focus on innovation and compliance, while navigating competitive and regulatory challenges [2][6][12]

Summary of the Conference Call for 康哲药业 (Kangzhe Pharmaceutical) Company Overview - 康哲药业 is undergoing a strategic transformation from pursuing sustainable growth to focusing on depth and breadth development, including establishing R&D institutions, investing in product centers, and introducing new products [2][3][4] Key Industry Insights - The company is prioritizing internationalization, targeting Southeast Asia and the Middle East markets, while also focusing on dermatology and ophthalmology in China [2][4] - 德美医药 (Demei Pharmaceutical), a subsidiary, is positioned as a leading innovative pharmaceutical company in skin health, with a projected revenue of 618 million yuan in 2024 and a compound annual growth rate (CAGR) of over 50% expected in the next five years [2][9] Core Points and Arguments - The decision to spin off 德美医药 aims to showcase 康哲's transformation achievements and to allow 德美 to operate independently, enhancing shareholder value without diluting existing equity [3][8] - 德美医药 has developed a rich product line from a single product, with several products achieving annual sales of hundreds of millions, and is expected to become profitable by 2026 [5][32] - 康哲's original business is expected to maintain a growth rate of over 10% post-spin-off, driven by exclusive products and new market contributions [3][26] Financial Performance and Projections - 德美医药's revenue for the past three years was 384 million (2022), 473 million (2023), and is projected to reach 618 million (2024) [9] - The skin disease treatment and care market in China is valued at 76.4 billion yuan, with a projected CAGR of over 10% until 2035 [9] Product Development and Market Strategy - 德美医药 has established a skin health research institute and plans to launch at least two new products annually, focusing on unmet clinical needs in skin diseases [11][16] - The company has a diverse product matrix, including treatments for psoriasis and atopic dermatitis, with significant market potential [12][14] R&D and Commercialization - 德美医药's R&D budget is set at no less than 200 million yuan annually, with a commitment to increasing investment by over 30% CAGR [30] - The company has over 650 sales personnel covering more than 10,000 pharmacies and hospitals, enhancing its market reach [37] Future Outlook - 德美医药 aims for a 50% CAGR in revenue over the next five years, driven by new product launches and enhanced market penetration [28][32] - The spin-off is expected to be completed with an IPO planned for 2025, with sufficient capital to support growth and profitability [36] Additional Considerations - The impact of the centralized procurement policy on profit margins and the strategic response to maintain competitive advantages in exclusive innovative drugs [17][23] - The potential for collaboration with other pharmaceutical companies to expand product offerings and market presence [22][31]

Summary of Conference Call Records Company Overview - The company, 移卡, is a technology platform focused on payment solutions, leveraging AI and data analytics to meet merchants' digital needs. The company has a significant annual transaction volume of approximately 2.3 trillion yuan, with overseas transaction volume growing at five times the rate of previous years, contributing to strong profitability and cash flow [3][4][5]. Industry Insights - The cross-border payment industry is undergoing significant changes due to trade tensions and tariff policies. Companies are restructuring their trade chains to mitigate impacts, which presents more opportunities for 移卡's full network payment channels to charge fees at various stages [6][7]. - The CIPS (Cross-Border Interbank Payment System) is growing rapidly, with a projected growth rate exceeding 40% in 2024, although it is currently not expected to replace SWIFT in the short term [11]. Key Points Financial Performance - 移卡's overseas payment business has seen transaction volume increase fivefold, with strong profitability and cash flow. The revenue structure has improved, with value-added service revenue rising to over 80%, leading to an increase in overall profit margin from 18.7% in 2023 to 24% in 2024 [4][5]. - The net profit for 2024 is projected to rise sixfold to 73 million yuan, with EBITDA reaching 390 million yuan. The debt-to-asset ratio has decreased from 45% to 35.9% [4]. Market Expansion - 移卡 is actively expanding in Southeast Asia, focusing on partnerships with local service providers to meet the consumption needs of Chinese consumers in regions like Southeast Asia and Japan [3][10]. - The company plans to maintain exponential growth by expanding its presence in Southeast Asia, particularly in countries like Malaysia and Indonesia, and by offering both payment and non-payment value-added services [9][10]. AI Integration - 移卡 has fully embraced AI technology to optimize risk control and improve R&D efficiency. The introduction of AI agents has enhanced customer service and reduced costs, with net profit expected to rise significantly due to these innovations [2][14][17]. - AI technology has improved risk management capabilities, processing approximately 20 million risky transactions in 2024, and has increased coding efficiency by 30% through automation [17]. Domestic Market Dynamics - In the domestic market, despite a decrease in average transaction value due to macroeconomic conditions, transaction frequency has increased, maintaining total transaction volume. The company anticipates significant growth in GPV (Gross Payment Volume) in 2025 due to improving consumer sentiment and macroeconomic policies [12][13]. Future Outlook - 移卡's future strategies include enhancing AI applications to further improve operational efficiency and exploring new areas for AI integration to drive growth in 2025 and 2026 [18]. Additional Insights - The company is focusing on high-value clients, such as gas stations, which are less price-sensitive and have higher service quality demands, contributing to improved overall fee rates and profitability [13]. - The company is also adapting its strategies to include diverse industry coverage, such as maternal and infant products, to capture future growth opportunities [12].

Summary of Conference Call Records Company Overview - The company, referred to as "子不语," is one of the largest cross-border e-commerce companies in the footwear and apparel category in China, headquartered in Hangzhou. It operates through multiple subsidiaries in cities like Guangzhou, Shenzhen, Dongguan, Fuzhou, Ningbo, and Vietnam, utilizing a global, multi-channel, and multi-platform business model [2][3]. Financial Performance - In 2024, the company achieved a revenue of 3.3 billion yuan, representing a year-on-year growth of 10.8%. The gross margin improved to 24.7%, and the net profit attributable to shareholders was 150 million yuan, marking a turnaround from previous losses. Operating cash flow reached 260 million yuan, with cash reserves of 450 million yuan, an increase of 61% year-on-year [1][2][3]. Strategic Focus - The company is shifting its strategic focus towards the Amazon platform, concentrating on ten core brands to penetrate the high-end market. These brands contributed approximately 35% of total revenue in 2024, with expectations to increase to over 45% in 2025 [1][6]. - The core brands include R 高端 (high-end independent site), CCBell, Solid Muscle, Very, Tencel, Yankati, Hello Morning, Control, and UCB [1][6]. Market Dependency and Diversification - The U.S. market accounts for over 95% of the company's cross-border e-commerce business. To mitigate reliance on the U.S. market and Amazon, the company aims to reduce this dependency to below 90% by 2025 through a diversification strategy and global supply chain layout [2][10]. - The company plans to increase overseas production capacity to over 20% of total capacity by 2025, currently relying on approximately 200 OEM manufacturers [2][18][19]. Cost Structure and Tariff Impact - The cost structure includes product costs (20%), freight (2%-4%), marketing (15%), platform fees (15%), and internal salaries (7%-8%). Tariff costs are approximately 3% of total costs, expected to rise to 5%-6% due to increased tariffs [2][11][12]. - The company employs a shipping strategy primarily using sea freight, supplemented by air freight, to manage costs associated with tariffs. The impact of tariffs is more pronounced on air freight and small package direct mail [1][8][12]. Inventory and Pricing Strategy - The company has a significant inventory buffer, with 80% of total inventory in overseas warehouses or in transit. Price increases may lead to a decline in sales, but the exact impact will depend on various sensitivity assumptions [9][13]. - Currently, the company has not implemented price increases but is considering an average increase of around 1 USD per item in response to rising costs [13][24]. Future Market Expansion - The company plans to accelerate development in emerging markets, including Europe, the Middle East, and Australia, while maintaining a focus on high-value products through independent sites [22][23]. - There are no plans to shift towards domestic sales due to intense competition in the domestic apparel market [23]. Seasonal Trends - The company experiences significant seasonal sales, particularly in the first and fourth quarters, with promotional activities contributing to higher revenue during these periods [28]. Conclusion - The company is navigating a complex landscape of tariffs and market dependency while strategically positioning itself for growth through brand focus, market diversification, and supply chain optimization. The emphasis on high-end products and overseas production capacity is expected to enhance competitiveness in the global market.

Summary of the Conference Call Records Company Overview - Lianlian Digital focuses on cross-border payments, accounting for approximately 70% of its business, providing multi-currency payment accounts for small and micro enterprises in China, facilitating global trade fund collection and domestic distribution. In 2024, the company is expected to process transaction volumes of 281.5 billion RMB, corresponding to a trade scale of approximately 560 billion RMB, serving about one-quarter of the Chinese export consumer goods cross-border e-commerce market [1][2][3]. Industry Characteristics - The cross-border payment industry requires global payment licenses, a comprehensive compliance payment system (KYC, anti-money laundering, trade authenticity verification), and strong service capabilities. Lianlian Digital is the only foreign company to obtain payment licenses in all 50 states in the U.S. and collaborates with several global settlement banks to provide efficient and secure payment services [1][4][5]. Competitive Landscape - The cross-border payment industry is characterized by a "three big, two small" structure, with Lianlian Digital, PingPong, and Payoneer each holding about 20% market share, while Airwallex and Worldfirst hold about 10% each. Notably, Airwallex's main business is not cross-border trade payments [1][7]. Revenue Sources and Growth - Lianlian Digital's domestic third-party online payment business has an annual transaction volume of 3 trillion RMB, contributing 30% of its revenue. The company collaborates with independent third-party ToB companies to provide differentiated payment solutions for approximately 3,000 large and medium-sized enterprises in China [2][13][26]. Financial Performance - In 2024, despite global economic pressures, Lianlian Digital achieved significant growth, with global transaction volume increasing by 63% and revenue by 23%. Domestic transaction volume grew by 65%, with revenue increasing by 57% [14][28]. Strategic Partnerships - The partnership with American Express for a clearing company has historically led to losses, but with recent capital increases from American Express, the company expects to achieve breakeven or profitability in the future, recovering approximately 1.6 billion RMB and enjoying investment returns [2][15]. Regulatory Compliance - Lianlian Digital holds relevant payment licenses in both China and the U.S., ensuring strong compliance. The company was one of the first to obtain a third-party online payment license in China and has completed all regulatory requirements [9][10]. Service Offerings - Lianlian Digital provides a one-stop solution that includes rapid matching of bank accounts in over 100 countries, covering 130 currencies, and connecting to over 100 global platforms for store setup. The company also offers logistics, digital marketing, and supply chain financial services through partnerships [11][12]. Market Challenges and Responses - In response to the U.S.-China trade war, Lianlian Digital has focused on real trade, supported new business developments (such as Web3 payments), and collaborated with the Ministry of Commerce to promote the digital transformation of offline trade [2][17]. Future Outlook - The company anticipates that the gap between transaction volume growth and revenue growth will narrow as historical small and medium customers grow into larger clients, leading to higher fee rates. The service trade sector is expected to maintain rapid growth, with Lianlian Digital taking a cautious approach to ensure compliance [21][25]. Conclusion - Lianlian Digital is well-positioned in the cross-border payment industry with a strong compliance framework, significant market share, and a comprehensive service offering. The company is adapting to market challenges and exploring new growth opportunities while maintaining a focus on regulatory compliance and customer service.

Summary of Conference Call Records Company: 复宏汉霖 (Fuhong Hanlin) Key Points Industry Overview - The company is navigating potential drug tariff increases by lowering supply prices and patent licensing fees to maintain product competitiveness and reduce cost burdens, ensuring effective overseas market operations [1][2][3] - The company is considering transferring production rights to overseas partners to utilize manufacturing bases in low-tax countries or establishing an antibody company in Saudi Arabia to mitigate tariff impacts on profits [1][4] Clinical Trials and Regulatory Environment - Despite strict U.S. data protection policies, the impact on the company's clinical trials in the U.S. is limited due to the small sample sizes typically involved, which do not require large-scale genetic testing [1][8] - The new U.S. regulations on cross-border data transmission, effective April 8, 2025, may affect Chinese companies conducting clinical trials in the U.S., but the specific impacts are still to be observed [7] Product Development and Market Strategy - The company plans to launch eight biopharmaceuticals in the U.S. market over the next four years, including already marketed products and those expected to be approved soon [1][14] - The company aims to drive global first-to-market strategies for biosimilars while maintaining a dual strategy of innovative drugs and biosimilars [28] Revenue and Royalty Structure - The company's royalty range typically falls between 25% and 35% of net sales, with a future inclination towards profit-sharing models that could reach up to one-third of net profits [1][12] - The overseas revenue expectations are tied to accounting standards that require revenue to be recognized over multiple years, indicating that cash income from business development deals is expected to increase compared to the previous year [13] Market Position and Competitive Landscape - The company has established criteria for selecting overseas partners, focusing on global capabilities and strong performance in both mainstream and emerging markets [1][11] - The pricing of Chinese biosimilars is generally comparable to overseas markets, with specific examples showing stable pricing in China due to inclusion in medical insurance [18] Future Outlook - The company is not currently considering entering the medical insurance market for its product, thinking it has unique indications that warrant exclusivity [16] - The potential for collective procurement of biosimilars is anticipated to be low this year, with a possibility for next year, depending on whether it is led by individual provinces or at the national level [15] Challenges and Opportunities - The high cost of production in the U.S. is a significant barrier, leading most companies to avoid full production transfers to the U.S. despite some multinational companies announcing investments [5][6] - The company is actively expanding its international partnerships and plans to build its commercialization capabilities, particularly in Japan and the U.S. [28][29] Additional Insights - The company maintains a 100% success rate in delivering products, which enhances its credibility and attractiveness to potential partners [29] - The U.S. market remains a critical target for innovative drugs, with ongoing discussions about high drug prices and their implications for market access and innovation [25][24]

Summary of Zhongshou's Conference Call Company Overview - Zhongshou's overseas revenue reached RMB 272 million in 2024, accounting for 14.1% of total revenue, with significant contributions from the game "Douluo Dalu: Shrek Academy" in the Hong Kong, Macau, and Taiwan markets [1][3] - The company plans to expand its overseas business by launching "Douluo Dalu: Reverse Time" in international markets [1][3] Core Business Segments - Zhongshou's game publishing revenue for 2024 was RMB 1.665 billion, with three main business segments: game publishing, game development, and IP licensing [2] - Key games launched include "Douluo Dalu: Shrek Academy," "Doupo Cangqiong: Peak Showdown," and "Douluo Dalu: Reverse Time," all performing exceptionally well [2][15] - The company aims to launch 18 new games in 2025, focusing on high-quality IP games and innovative mini-games [2][10] Long-term Operating IP Games - Zhongshou has several long-term operating IP games, including "Xianjian Qixia Chuan," "One Piece: Bloodline," and "True Three Kingdoms: Domination," which have shown strong revenue performance [4] - "New Legend of the Condor Heroes: Iron Blood and Heart" generated RMB 260 million in its first month, while "One Piece: Bloodline" has maintained active engagement since its launch [4] Research and Development - The company invested RMB 244 million in R&D in 2024, focusing on projects like "Code: Dark Night Legend" and the open-world game "Xianjian World" [5] - "Xianjian World" was launched in early 2025, while "Code: Dark Night Legend" is expected to enter testing later in 2025 [5][13] IP Licensing Achievements - In 2024, IP licensing revenue was RMB 116 million, with Zhongshou holding complete global rights to "Xianjian Qixia Chuan" [7] - The company collaborates with partners like iQIYI and Tencent to produce series based on the IP, enhancing its market presence [8] Mini-Game Platform - The mini-game platform has lower channel costs and higher profit margins, with "Chunqiu Xuanqi" generating over RMB 100 million in its second month [17] - The company aims to deepen its development in the mini-game sector, targeting a revenue increase [17] Overseas Market Strategy - Zhongshou began its overseas business in 2021, with revenue contribution rising from less than 1% to over 10% in the first year [19] - The company plans to accelerate its overseas expansion, targeting a revenue contribution of 20% to 30% from international markets in the next three years [19][20] Future Outlook - The company is considering stock buybacks and dividends based on market conditions, with ongoing support from major shareholders [21] - The competitive landscape in the gaming market remains intense, but Zhongshou's strong IP portfolio positions it favorably [16]